EVENT BIO
See breakdown of all you need to know about our Summit
HOT CONFERENCE TOPICS
- The Internet of Medical Things: Leveraging technology to drive clinical behaviour change
- The importance of strategic thinking for the future role of medical affairs
- How to define the right level of medical affairs activities
- How can RWD best contribute to optimising drugs value proposal?
- Medical affairs as an internal voice for the patients
- Medical affairs leading strategic partnerships: Building a bolder medical affairs vision
- Delivering the next generation of medicines and vaccines to the patients: The digitally-enhanced role of MSLs
2nd Annual Global Medical Affairs Summit has been designed to bring you a unique opportunity to gain fresh insights into medical and scientific affairs areas. Come and find the answers to all the questions about the importance of strategic thinking for the future role of medical affairs and how to leverage technology to drive clinical behaviour change. You will hear about the customer centricity and the power of a patient story in medical affairs, and we will analyse how to reach company’s objectives by staying ethical. By attending this summit, you will access the first-hand learnings and valuable tips when it comes to health affairs improvement strategy from senior experts of the major pharmaceutical companies.
WHO WILL YOU MEET
Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors, and Heads of departments from pharma industry involved in:
- Medical Science Liaisons (MSL)
- Scientific Affairs
- Real World Evidence
- Commercial Excellence
- Market Access
- KOL/Thought Leader Relations/Engagement
- Clinical Affairs
- Medical Review
- Health Economics and Outcomes Research/HEOR
- Medical Information
- Medical Writing
- Product Launch
- Patient Outcome
- Patient Centricity
- Digital Medical
- Customer Value
- Scientific Engagement
- Scientific Partnerships
- Commercial Operations
- External Affairs
- Medical and Scientific Communication
- Medical Affairs Operations
- Medical Strategy
- Policy & Market Access
- Portfolio Planning
- Launch Management
- Medical/Scientific/Patient Communications
- Scientific Information
